What is it about?

The study assessed the antihypertensive and antihyperlipidemic effects of quercetin, epigallocatechin-3-gallate (EGCG), and anthocyanins, focusing on their potential as nutraceuticals for managing cardiovascular diseases. The methodology included a review of clinical trials retrieved from databases like PubMed and Scopus, using specific search strings related to each compound's effects on blood pressure and lipid profiles. The investigation was limited to studies published from 2000 to April 2024. Main findings indicated that quercetin, when consumed in dietary forms such as onions, led to dose-dependent reductions in blood pressure and modest decreases in low-density lipoprotein cholesterol (LDL-C). EGCG, often consumed through green tea, showed consistent reductions in both systolic and diastolic blood pressure, along with improvements in lipid metabolism. Anthocyanins, sourced from berries, demonstrated the most significant impact on blood pressure reduction and LDL-C improvement. Despite these promising results, the study highlighted inconsistencies in trial designs, underscoring the need for standardized, long-term research.

Featured Image

Why is it important?

This study is important as it explores the potential of dietary secondary metabolites to address cardiovascular diseases (CVDs), the leading cause of mortality globally. By focusing on naturally occurring compounds like EGCG, quercetin, and anthocyanins, the research highlights a cost-effective and accessible strategy for mitigating hypertension and hyperlipidemia, which are significant modifiable risk factors for CVDs. The findings suggest that integrating these compounds into daily diets could lead to significant public health benefits by reducing the prevalence and economic burden of CVDs, thus offering an alternative or adjunct to conventional pharmacotherapy. Key Takeaways: 1. Significant Blood Pressure Reduction: The study reveals that consumption of anthocyanins from berries results in substantial reductions in both systolic and diastolic blood pressure, with improvements also noted in LDL-C and HDL-C levels. 2. Modest Cholesterol Improvement: EGCG from green tea shows modest but consistent reductions in blood pressure and LDL-C, with mechanisms involving endothelial nitric oxide synthase activation and lipid metabolism enhancement. 3. Dietary Integration Feasibility: Incorporating quercetin, EGCG, and anthocyanins into everyday foods like salads, beverages, and juices leverages culturally acceptable eating patterns, potentially enhancing adherence and offering a sustainable approach to cardiovascular health management.

AI notice

Some of the content on this page has been created using generative AI.

Read the Original

This page is a summary of: Nutraceuticals Against the Silent Killers: Role of Secondary Metabolites in the Prevention and Management of Hypertension and Hyperlipidemia, Premier Journal of Cardiology, September 2025, Premier Science,
DOI: 10.70389/pjc.100013.
You can read the full text:

Read
Open access logo

Contributors

Be the first to contribute to this page